Primary Site >> Pancreatic Cancer

Gene >> NEU1

  • 2013
  • 2014
  • 2016
  • 2017
  • 2018
Ref: A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
PMID: 23993964
Ref: Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu(R)) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance.
PMID: 24470763
Ref: A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.
PMID: 25184537
Ref: Oseltamivir-conjugated polymeric micelles prepared by RAFT living radical polymerization as a new active tumor targeting drug delivery platform.
PMID: 26788555
Ref: Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival.
PMID: 28814832
Ref: Oseltamivir phosphate released from injectable Pickering emulsions over an extended term disables human pancreatic cancer cell survival.
PMID: 29560107